Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) — The “Nephrology And Urology Devices – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Nephrology And Urology Devices was estimated at US$26.3 Billion in 2023 and is projected to reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The importance of nephrology and urology devices lies in their ability to enhance the quality of life for patients by enabling effective disease management, faster recovery, and less invasive procedures. For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function and prolonging life. In cases of urological disorders, devices like stents, catheters, and laser systems allow for effective management of obstructions, infections, and other complications.
What Drives Growth in the Nephrology and Urology Devices Market?
The growth in the nephrology and urology devices market is driven by several factors, including increasing prevalence of kidney and urological disorders, rising demand for minimally invasive treatments, and advancements in medical technology. One of the primary growth drivers is the global rise in chronic kidney disease and end-stage renal disease, largely due to aging populations, lifestyle changes, and higher rates of diabetes and hypertension. As more patients require long-term management and renal replacement therapy, the demand for dialysis machines, catheters, and other related devices has increased, supporting market expansion.
The growing preference for minimally invasive surgical techniques has also fueled demand for advanced urology devices. Patients and healthcare providers are increasingly opting for treatments that offer quicker recovery, reduced pain, and fewer complications. Minimally invasive technologies, such as laser lithotripsy for kidney stones and robotic-assisted surgery for prostate and kidney tumors, have become popular choices, driving demand for ureteroscopes, lasers, and robotic systems. This shift toward less invasive interventions has supported the adoption of innovative devices that offer better precision, safety, and effectiveness in treating kidney and urological disorders.
Advancements in medical technology, including digital health tools and portable devices, have contributed to market growth by improving access to care and patient outcomes. Innovations like wearable sensors, remote monitoring devices, and mobile health applications allow for continuous monitoring of patients with chronic conditions, supporting better disease management and timely interventions. For instance, home-based dialysis machines enable more patients to receive treatment outside traditional clinical settings, enhancing convenience and reducing healthcare costs. These advancements align with broader healthcare trends toward personalized, patient-centric care and integrated digital solutions.
Government initiatives and healthcare infrastructure development have also played a key role in driving the nephrology and urology devices market. Increased healthcare spending, improved insurance coverage, and public awareness campaigns about kidney and urological health have boosted the adoption of medical devices in both developed and developing regions. Regulatory support for new device approvals and reimbursement policies has further facilitated access to advanced treatment options, ensuring broader availability of nephrology and urology devices in global markets.
With ongoing innovations in medical devices, telehealth, and minimally invasive techniques, the nephrology and urology devices market is poised for continued growth. These trends, combined with increasing demand for effective disease management, improved patient outcomes, and advanced treatment options, make nephrology and urology devices vital components of modern healthcare strategies across diverse patient populations.
What Are the Emerging Applications of Nephrology and Urology Devices Across Different Patient Groups?
Nephrology and urology devices are finding expanding applications across diverse patient groups, driven by increasing prevalence of kidney and urological disorders and the need for more effective, less invasive treatment options. In the treatment of kidney stones, for example, ureteroscopes, lithotripters, and stents are widely used to facilitate stone removal or fragmentation. These devices are commonly employed across adult and pediatric populations, offering effective solutions for acute management and long-term prevention of recurrence. The use of extracorporeal shock wave lithotripsy (ESWL), which breaks down stones non-invasively, has become a preferred treatment method due to its minimal complications and faster recovery times.
For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function. Hemodialysis and peritoneal dialysis devices serve different patient needs, with hemodialysis being more common in clinical settings and peritoneal dialysis offering greater flexibility for home-based care. Recent advancements have focused on improving patient comfort, reducing treatment duration, and enhancing efficiency. Portable dialysis machines, for instance, allow patients to receive dialysis at home or while traveling, providing more autonomy and a better quality of life.
In the management of benign prostatic hyperplasia (BPH), devices like prostatic stents, transurethral resection of the prostate (TURP) equipment, and laser systems have become standard treatment options, particularly among older male patients. These devices provide effective relief from urinary obstruction and improve urine flow, offering minimally invasive solutions with shorter hospital stays and reduced risks of complications. In addition, urinary incontinence devices, such as catheters, slings, and sacral neuromodulation implants, offer targeted solutions for different types of incontinence, addressing the needs of both male and female patients across a wide age range.
In cancer treatment, nephrology and urology devices are used for biopsy, tumor ablation, and surgical interventions. Devices like laparoscopic nephrectomy tools, cystoscopes, and laser ablation systems allow for precise removal or treatment of cancerous tissues while preserving healthy structures. The use of advanced imaging technologies in conjunction with these devices has improved early detection, diagnosis, and targeted treatment of cancers like renal cell carcinoma and bladder cancer. The expanding applications of nephrology and urology devices across these patient groups highlight their critical role in enhancing patient outcomes, improving quality of life, and supporting comprehensive care for kidney and urological disorders.
Scope of the Study
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Nephrology And Urology Devices Market such as Asahi Kasei Corp, B. Braun Group, Boston Scientific Corporation, Siemens Healthineers, Cardinal Health Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Dialysis Devices segment, which is expected to reach US$28.9 Billion by 2030 with a CAGR of a 6.2%. The Endoscopy Devices segment is also set to grow at 5.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $7.0 Billion in 2023, and China, forecasted to grow at an impressive 8.9% CAGR to reach $9.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Segments
- Dialysis Devices
- Endoscopy Devices
- Benign Prostatic Hyperplasia (BPH) Treatment Devices
- Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices
- Urinary Stone Treatment Devices
- Other Types
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $26.3 Billion |
| Forecasted Market Value (USD) by 2030 | $39.3 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Nephrology And Urology Devices – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Incidence of Kidney Disorders Drives Demand for Nephrology Devices
- Expanding Geriatric Population Sets the Stage for Urology Device Adoption
- Growing Focus on Minimally Invasive Surgeries Propels Device Demand
- Advancements in Dialysis Technology Strengthen Business Case for Nephrology Devices
- Increasing Use of Catheters in Urology Drives Market Growth
- Use in Robotic-assisted Urological Surgeries Expands Addressable Market
- Growing Applications in Prostate Treatment Enhance Demand for Devices
- Rising Focus on Home-based Dialysis Sets the Stage for Nephrology Device Growth
- Increasing Demand for Incontinence Management Drives Urology Device Market
- Advancements in Stents Propel Demand for Nephrology and Urology Devices
- Strategic Focus on Telehealth Solutions Generates Opportunities
- Increasing Use of Nephrostomy Devices Generates Demand
- Strong Growth in Ambulatory Surgical Centers Drives Nephrology Device Demand
FOCUS ON SELECT PLAYERS:Some of the 41 companies featured in this report include
- Asahi Kasei Corp
- B. Braun Group
- Boston Scientific Corporation
- Siemens Healthineers
- Cardinal Health Inc.
- Cook Group Incorporated
- Dornier Medtech
- Medtronic plc
- Olympus Europa SE & Co. KG
- Teleflex Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mcbhpb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Nephrology And Urology Devices Market
